NVCT
Income statement / Annual
Last year (2025), Nuvectis Pharma Inc's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2025, Nuvectis Pharma Inc's net income was -$26.44 M.
See Nuvectis Pharma Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$18.15 M
|
$12.92 M
|
$15.38 M
|
$13.23 M
|
$9.55 M
|
$0.00
|
| General & Administrative Expenses |
$9.42 M
|
$6.93 M
|
$7.52 M
|
$6.01 M
|
$3.35 M
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$9.42 M
|
$6.93 M
|
$7.52 M
|
$6.01 M
|
$3.35 M
|
$10.00 K
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$27.57 M
|
$19.85 M
|
$22.90 M
|
$19.23 M
|
$12.89 M
|
$10.00 K
|
| Cost And Expenses |
$27.57 M
|
$19.85 M
|
$22.90 M
|
$19.23 M
|
$12.89 M
|
$10.00 K
|
| Interest Income |
$1.13 M
|
$847.00 K
|
$637.00 K
|
$149.00 K
|
$4.00 K
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| EBITDA |
-$27.57 M |
-$19.00 M |
-$22.90 M |
-$19.23 M |
-$12.89 M |
-$10.00 K |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$1.13 M
|
$847.00 K
|
$637.00 K
|
$149.00 K
|
$4.00 K
|
$0.00
|
| Income Before Tax |
-$26.44 M
|
-$19.00 M
|
-$22.26 M
|
-$19.09 M
|
-$12.89 M
|
-$10.00 K
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$26.44 M
|
-$19.00 M
|
-$22.26 M
|
-$19.09 M
|
-$12.89 M
|
-$10.00 K
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-1.32 |
-1.11 |
-1.43 |
-1.51 |
-1.09 |
-0.0008 |
| EPS Diluted |
-1.32 |
-1.11 |
-1.43 |
-1.51 |
-1.09 |
-0.0008 |
| Weighted Average Shares Out |
$21.81 M
|
$17.11 M
|
$15.56 M
|
$12.66 M
|
$12.72 M
|
$12.72 M
|
| Weighted Average Shares Out Diluted |
$21.81 M
|
$17.11 M
|
$15.56 M
|
$12.66 M
|
$12.72 M
|
$12.72 M
|
| Link |
|
|
|
|
|
|
